Placenta percreta with bladder involvement: a case report at a tertiary care centre

C. P. Dadhich; Nidhi Mehta; Tripti Dadhich; Surmil Sharma

doi:10.18203/2320-1770.ijrcog20264026

Authors

C. P. Dadhich Department of Obstetrics and Gynaecology, CK Birla Hospital, Jaipur, Rajasthan, India
Nidhi Mehta Department of Obstetrics and Gynaecology, CK Birla Hospital, Jaipur, Rajasthan, India
Tripti Dadhich Department of Obstetrics and Gynaecology, CK Birla Hospital, Jaipur, Rajasthan, India
Surmil Sharma Department of Obstetrics and Gynaecology, CK Birla Hospital, Jaipur, Rajasthan, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20264026

Keywords:

Placenta accreta spectrum, Placenta percreta, Caesarean hysterectomy, Antenatal diagnosis, Multidisciplinary management

Abstract

Placenta accreta spectrum (PAS), encompassing placenta accreta, increta, and percreta, represents one of the most severe and life-threatening obstetric conditions. The rising incidence of Placenta Accreta Spectrum parallels the increasing rates of caesarean delivery. Caesarean hysterectomy with the placenta left in situ remains the standard management strategy for placenta percreta; however, even in tertiary care settings, it is associated with significant maternal morbidity. Early antenatal diagnosis facilitates planned delivery and multidisciplinary management, thereby improving maternal outcomes. We report a case of placenta percreta managed at a tertiary care centre, highlighting intraoperative challenges, postoperative complications, and adherence to FOGSI-recommended management protocols.

References

Jauniaux E, Ayres-de-Campos D; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int J Gynaecol Obstet. 2018;140(3):265-73.

Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat caesarean deliveries. Obstet Gynecol. 2006;107(6):1226-32.

Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM. Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol. 2014;31(9):799-804.

Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010;203(5):430-9.

Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol. 2005;26(1):89-96.

D'Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;42(5):509-17.

Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J. FIGO consensus guidelines on placenta accreta spectrum disorders: diagnosis and management. Int J Gynaecol Obstet. 2018;140(3):281-90.

Committee on Obstetric Practice. Placenta accreta spectrum. ACOG Obstetric Care Consensus No. 7. Obstet Gynecol. 2018;132(6).

Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115(3):526-34.

Society of Obstetricians and Gynaecologists of India (FOGSI). Good clinical practice recommendations on placenta accreta spectrum. Mumbai: FOGSI; [year to be confirmed].